Lv21
180 积分 2023-08-24 加入
Metabolic dysfunction-associated fatty liver disease subgroups and risk of hepatocellular carcinoma and mortality in patients with chronic viral hepatitis
8小时前
待确认
Correlation between non-invasive measures of fibrosis and FibroScan: An update on local experience
9小时前
已完结
Effect of metabolic dysfunction‐associated fatty liver disease on liver cancer risk in a population with chronic hepatitis B virus infection: A nationwide study
9小时前
已完结
The beneficial impact of metabolic dysfunction‐associated fatty liver disease on lenvatinib treatment in patients with non‐viral hepatocellular carcinoma
10小时前
已完结
The impact of metabolic dysfunction–associated fatty liver disease on the prognosis of patients with hepatocellular carcinoma after radical resection
10小时前
已完结
Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002–2033: the ITA.LI.CA database
10小时前
已完结
Statins for MAFLD/MASH: another brick in the wall while waiting for final answers
4天前
已完结
Letter to the editor: Autoimmune gastritis may be less susceptible to cancer development thanHelicobacter pylori-related gastritis based on histological analysis
4天前
已完结
Morphological consistency between EUS and ERCP in diagnosing biliary sludge and microlithiasis
4天前
已完结
Endoscopic stratification of gastric intestinal metaplasia: where are we, where do we want to go and how do we get there?
4天前
求助中
皖公网安备34019202002308
